Washington, July 28 -- Congressman Chris Pappas issued the following press release:
Three bipartisan bills backed by Congressman Chris Pappas (NH-01) were voted out of the House Committee on Energy and Commerce last week, and now head to the House floor for a vote before the full House of Representatives.
Pappas introduced the bipartisan, bicameral Combating Illicit Xylazine Act with Rep. Jimmy Panetta (CA-19), which would list xylazine as a Schedule III controlled substance and give law enforcement the tools they need to go after traffickers while protecting the drug's legal use by veterinarians, farmers, and ranchers. Xylazine, also known as "tranq," is an easily accessible veterinary tranquilizer that is being used as a low-cost cutting...